Viking Therapeutics, Inc. — Director's Dealing 2021

Jan 6, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Viking Therapeutics, Inc. (VKTX)
CIK: 0001607678
Period of Report: 2021-01-04

Reporting Person: Mancini Marianna (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.00001 per share	94655	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.68	2030-03-31	Common Stock (18000)		Direct
Stock Option (Right to Buy)	$7.77	2030-01-03	Common Stock (54000)		Direct
Stock Option (Right to Buy)	$6.47	2029-10-31	Common Stock (4000)		Direct
Stock Option (Right to Buy)	$7.69	2029-07-31	Common Stock (10000)		Direct
Stock Option (Right to Buy)	$8.52	2029-01-15	Common Stock (23100)		Direct
Stock Option (Right to Buy)	$13.07	2028-08-31	Common Stock (12500)		Direct
Stock Option (Right to Buy)	$4.37	2028-03-30	Common Stock (30000)		Direct
Stock Option (Right to Buy)	$4.65	2028-01-19	Common Stock (24500)		Direct
Stock Option (Right to Buy)	$1.04	2027-08-31	Common Stock (10000)		Direct
Stock Option (Right to Buy)	$1.08	2027-06-30	Common Stock (15000)		Direct
Stock Option (Right to Buy)	$1.23	2027-01-05	Common Stock (23054)		Direct
Stock Option (Right to Buy)	$1.23	2027-01-05	Common Stock (30000)		Direct
Stock Option (Right to Buy)	$1.26	2026-06-30	Common Stock (15000)		Direct
Stock Option (Right to Buy)	$1.88	2026-03-14	Common Stock (4873)		Direct
Stock Option (Right to Buy)	$2.15	2026-03-04	Common Stock (15000)		Direct
Stock Option (Right to Buy)	$9.13	2025-05-21	Common Stock (15000)		Direct

Footnotes

F1: Includes (a) 2,334 shares subject to a restricted stock unit award ("RSU") of common stock that was granted on January 19, 2018 under the Issuer's 2014 Equity Incentive Plan, of which one-third of the original 7,000 shares subject to the RSU vested or shall vest on each one year anniversary of the grant date of the award; (b) 5,950 shares subject to an RSU of common stock that was granted on January 15, 2019 under the Issuer's 2014 Equity Incentive Plan, of which 25% of the original 7,933 shares subject to the RSU vested or shall vest on each one year anniversary of the grant date of the award; and (c) 16,000 shares subject to an RSU of common stock that was granted on January 3, 2020 under the Issuer's 2014 Equity Incentive Plan, of which one-third of the original 24,000 shares subject to the RSU vested or shall vest on each one year anniversary of the grant date of the award.

F2: 25% of the shares subject to the option will vest on each one year anniversary of the grant date of March 31, 2020.

F3: 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of January 3, 2020.

F4: 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of October 31, 2019.

F5: One-third of the shares subject to the option vested or will vest on each one year anniversary of the grant date of July 31, 2019.

F6: 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of January 15, 2019.

F7: One-third of the shares subject to the option vested on the grant date and one-third of the shares subject to the option vested on each one year anniversary of the grant date of August 31, 2018.

F8: One-third of the shares subject to the option vested or will vest on each one year anniversary of the grant date of March 30, 2018.

F9: 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of January 19, 2018.

F10: 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of August 31, 2017.

F11: 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of June 30, 2017.

F12: The shares subject to the option vested on the grant date of January 5, 2017.

F13: 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of January 5, 2017.

F14: 25% of the shares subject to the option vested on each one year anniversary of the grant date of June 30, 2016.

F15: The shares subject to the option vested on the grant date of March 14, 2016.

F16: 25% of the shares subject to the option vested on each one year anniversary of the grant date of March 4, 2016.

F17: 25% of the shares subject to the option vested on each one year anniversary of the grant date of May 21, 2015.